Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2000
08/03/2000CA2360997A1 Non-invasive method for detecting target rna
08/03/2000CA2360690A1 Plasminogen kringle 4 region fragments and methods of use
08/03/2000CA2360672A1 Methods for preventing graft rejection and ischemia-reperfusion injury
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2360374A1 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
08/03/2000CA2360146A1 Methods for inhibiting brain tumor growth by using selected integrin antagonists
08/03/2000CA2360064A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
08/03/2000CA2359701A1 Nucleic-acid binding proteins
08/03/2000CA2359317A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000CA2359043A1 Transcription factor e2f dna-binding domain inhibitor peptides and their use
08/03/2000CA2359039A1 Meg-4 protein
08/03/2000CA2359030A1 Substituted phenethylamine derivatives
08/03/2000CA2357709A1 Internal ribosome entry site (ires), vector containing same and uses thereof
08/03/2000CA2326741A1 The use of gastrin in the treatment of diabetes
08/02/2000EP1024198A2 Pseudo-adenoviral vectors for the gene therapy of haemophiliae
08/02/2000EP1024197A2 Mesothelial cell gene therapy
08/02/2000EP1024192A2 Clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said proteins
08/02/2000EP1023906A1 Potentiator for antibody against lymphoid tumor
08/02/2000EP1023905A2 Pharmaceutical composition containing S-nitroso-immunoglobulins and use thereof
08/02/2000EP1023902A1 Pharmaceutical preparation for the treatment of inflammatory processes
08/02/2000EP1023901A1 Ameliorant for hepatitis c remedial effect and application thereof
08/02/2000EP1023900A2 Pharmaceutical composition containing S-nitroso-lipoproteins and use thereof
08/02/2000EP1023447A1 Human ribonuclease a with reduced ribonuclease inhibitor affinity
08/02/2000EP1023445A1 Cadherin derived growth factor and the application thereof
08/02/2000EP1023444A1 Cell division regulators
08/02/2000EP1023443A1 Mammoglobin homolog
08/02/2000EP1023441A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function
08/02/2000EP1023437A1 Receptor kinase, bin1
08/02/2000EP1023324A1 Trivalent thrombin inhibitor
08/02/2000EP1023323A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
08/02/2000EP1023322A1 Novel npy family member
08/02/2000EP1023321A1 Use of elicitins as lipid carriers
08/02/2000EP1023320A1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS
08/02/2000EP1023319A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
08/02/2000EP1023318A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin
08/02/2000EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules
08/02/2000EP1023313A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
08/02/2000EP1023311A1 Novel bacterial polypeptides and polynucleotides
08/02/2000EP1023288A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
08/02/2000EP1023084A1 Compositions for controlling bacterial colonization
08/02/2000EP1023082A1 Tumour vaccine
08/02/2000EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP1023078A1 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma
08/02/2000EP1023076A1 Use of the p-ten suppressor gene in diagnosis and treatment of cancer
08/02/2000EP1023067A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/02/2000EP1023064A1 12(s)-hete receptor blockers
08/02/2000EP1023058A2 Amelioration of ischemic damage using synthetic oxygen carriers
08/02/2000EP1023037A1 Plaque-inhibiting oral compositions
08/02/2000EP1022958A1 Increasing the digestibility of food proteins by thioredoxin reduction
08/02/2000EP1022951A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
08/02/2000EP1022945A2 Method and formulation for treating vascular disease
08/02/2000EP0923642A4 Active survival domains of igf-ir and methods of use
08/02/2000EP0828825A4 Methods of use of phthalocyanines to inactivate blood borne parasites
08/02/2000EP0729325A4 Osteogenic product and process
08/02/2000EP0630407B1 Anti-viral fusion peptides
08/02/2000EP0554383B1 Blood coagulation protein antagonists and uses therefor
08/02/2000EP0527889B1 Quinolizinone type compounds
08/02/2000CN1261896A Surface antigens and proteins useful in compositions for diagnosis and prevention of lyme disease
08/02/2000CN1261895A Cyclic azapeptide with angiogenic effect
08/02/2000CN1261894A Polyol-amino-acid compounds having anti-helicobactor pylori activity
08/02/2000CN1261873A Methods and compositions for selective modification of nucleic acids
08/02/2000CN1261807A Improved method for transferring nucleic acid into the striped muscle and combination therefor
08/02/2000CN1261806A Polyethylene glycol-interferon alpha conjugates for therapy of infection
08/02/2000CN1261804A Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor
08/02/2000CN1261803A Antioxidant enhancement of therapy for hyperproliferative conditions
08/02/2000CN1261802A Leptin as an inhibitor of tumor cell proliferation
08/02/2000CN1261801A Allelic polygene diagnosis of reward deficiency syndrome and treatment
08/02/2000CN1055123C Protein structure of plant torin gelonin
08/02/2000CN1055023C Wound nursing agent
08/02/2000CN1055022C Compound interferon antiviral drug. prepn. and use thereof
08/01/2000US6096885 Exhibit agonist activity for cck-a receptors thereby enabling them to modulate the hormones gastrin and cholecystokinin in mammals.
08/01/2000US6096880 Circular DNA vectors for synthesis of RNA and DNA
08/01/2000US6096879 Nucleotide sequence coding microorganismal protein; for the diagnosis of the presence of viral particles in serum
08/01/2000US6096877 Cdna sequences coding a protein with inhibitory activity
08/01/2000US6096876 1-α-hydroxylase materials and methods
08/01/2000US6096873 Mitogen polypeptide; for the treatment of nervous system and muscular disorders; anticarcinogenic agents
08/01/2000US6096871 Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
08/01/2000US6096869 Treatment of papillomavirus-associated lesions
08/01/2000US6096868 ECR 673: A 7-transmembrane G-protein coupled receptor
08/01/2000US6096866 Netrins
08/01/2000US6096864 Tetrapeptide for the treatment of injuries
08/01/2000US6096863 Self-assembling amphiphiles for construction of peptide secondary structures
08/01/2000US6096862 Multimeric antiviral agent
08/01/2000US6096785 Administering glycine to the human patient for treating renal dysfunction induced by cyclosporins or ascomycins
08/01/2000US6096778 α-ketoamide multicatalytic protease inhibitors
08/01/2000US6096764 Eliminating the detrimental side-effects associated with the continuous and chronic use of gondatropin-releasing hormone factor or agonist by administering to the patient an effective amount of benzothiophene derivatives
08/01/2000US6096756 Administering to a patient an analgesic amount of a bimodally-acting opioid agonist and an amount of an excitatory opioid receptor antagonist effective to enhance the analgesic potency of bimodally acting opioid agonist
08/01/2000US6096728 Composition and method for treating inflammatory diseases
08/01/2000US6096726 Multicomponent complex for use with substrate
08/01/2000US6096722 Non-steroidal treatment/prophylaxis
08/01/2000US6096716 Directly injecting to injured tissue of brain or spinal cord a nucleic acid segment encoding a neurotrophin and a liposome comprising cationic lipid(s)
08/01/2000US6096713 Administering to patient a linear or cyclized derivative of glutamic acid-tryptophan dipeptide or a low molecular weight oligo- or polypeptide based upon the dipeptide unit
08/01/2000US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents
08/01/2000US6096711 Contacting a aged cell with a proteasome inhibitor to induce production of the chaperone protein, hsp72
08/01/2000US6096709 Use of angiotensin II fragments and analogs thereof in tissue repair
08/01/2000US6096707 Cyclic oligo/polypeptide including an arginine-lysine-lysine-histidine sequence effective to inhibit integrin-dependent cell migration
08/01/2000US6096706 Growth-promoting proteins and peptides for kidney epithelial cells
08/01/2000US6096705 Contacting cell with drug which inhibits protein kinase from phosphorylating b2 adrenergic receptor specific to an agonist compound desired to affect cell
08/01/2000US6096551 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
1 ... 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 ... 3163